Why Surgery Partners (SGRY) stock is trading up today

What happened

HealthSpan Partners, an affiliate of Bon Secours Mercy Health, agreed to acquire Surgery Partners in an all-cash deal valued at about $5.7 billion. Shareholders will receive $23.50 per share, a 49% premium over the prior $15.75 close.

Confirmed

Global impact / market context

The takeover premium explains the stock jump, since buyers are paying well above the last traded price. Committed debt financing, which means the borrowed money is already arranged, lowers deal-completion risk for investors who hold shares until closing.

Analyst inference

Surgery Partners stock is highly volatile, with 18 single-day moves above 5% in the past year. A jump this large is unusually big, showing investors now view the business through the agreed buyout price rather than standalone earnings.

Analyst inference

What to watch

1. The deal is expected to close in the first quarter of 2027, subject to antitrust clearance and shareholder approvals, with a company termination fee of about $109 million if the agreement is broken. Confirmed
2. Watch whether Surgery Partners shareholders approve the $23.50 per-share cash offer, since their vote is a required step before the acquisition can be completed. Proposed
3. Any antitrust review delay could push the closing past early 2027, which matters because shareholders waiting for the $23.50 payout bear the risk that the deal falls apart. Analyst inference

Evidence

• stockstory.org